Zymeworks EPS - Earnings per Share 2016-2022 | ZYME

Zymeworks eps - earnings per share from 2016 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Zymeworks Annual EPS
2021 $-4.61
2020 $-3.58
2019 $-3.83
2018 $-1.26
2017 $-0.64
2016 $-2.65
2015 $-0.71
Zymeworks Quarterly EPS
2022-03-31 $-1.19
2021-12-31 $-1.18
2021-09-30 $-1.25
2021-06-30 $-1.31
2021-03-31 $-0.87
2020-12-31 $-0.74
2020-09-30 $-1.43
2020-06-30 $-0.77
2020-03-31 $-0.64
2019-12-31 $-1.81
2019-09-30 $-0.70
2019-06-30 $-0.89
2019-03-31 $-0.43
2018-12-31 $0.38
2018-09-30 $-0.59
2018-06-30 $-0.22
2018-03-31 $-0.83
2017-12-31 $1.89
2017-09-30 $-0.65
2017-06-30 $-0.63
2017-03-31 $-1.25
2016-12-31 $-0.89
2016-09-30 $-0.94
2016-06-30 $-0.58
2016-03-31 $-0.24
2015-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.309B $0.027B
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.746B 9.96
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.525B 16.61
Biohaven Pharmaceutical Holding (BHVN) United States $9.916B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.276B 0.00
Emergent Biosolutions (EBS) United States $1.438B 6.15
Arcus Biosciences (RCUS) United States $1.419B 35.98
Myovant Sciences (MYOV) United Kingdom $0.944B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.492B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.085B 0.00